Strategic Partners —

R&D Systems/TECHNE Corporation —
Our significant investor TECHNE Corporation, through their R&D Systems subsidiary, provides us with facilities, equipment and financial services. In addition, they purify our proteins and transposase, as well as being collaborators.

University of Minnesota —
The University of Minnesota provides us with the clinical leadership and facilities for our clinical trials in addition to exclusive licenses to some of our technology.

AngioGenetics AB —
Our collaborative agreement with AngioGenetics, a Swedish company, gives us a unique capability in angiogenesis — the formation of blood vessels — which in turn may lead to valuable patents applicable to cancer and ischemia.